Market Closed -
Canadian Securities Exchange
01:29:00 04/05/2024 am IST
|
5-day change
|
1st Jan Change
|
1.47
CAD
|
-9.26%
|
|
+17.60%
|
-36.91%
|
Fiscal Period: June |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
245.3
|
73.23
|
127.5
|
Enterprise Value (EV)
1 |
239.9
|
72.72
|
126.5
|
P/E ratio
|
-65.6
x
|
-9.83
x
|
-17.1
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-1,95,19,801
x
|
EV / FCF
|
-20,05,00,528
x
|
-2,24,00,014
x
|
-2,36,81,510
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
Price to Book
|
45.3
x
|
-189
x
|
81.6
x
|
Nbr of stocks (in thousands)
|
34,801
|
36,615
|
43,681
|
Reference price
2 |
7.050
|
2.000
|
2.920
|
Announcement Date
|
27/10/21
|
24/10/22
|
27/10/23
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-6.481
|
EBIT
1 |
-0.0419
|
-0.6732
|
-2.826
|
-7.274
|
-6.494
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.001946
|
-0.6732
|
-2.859
|
-7.344
|
-6.868
|
Net income
1 |
-0.001946
|
-0.6732
|
-2.859
|
-7.344
|
-6.763
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-0.7137
|
-0.1075
|
-0.2036
|
-0.1705
|
Free Cash Flow
|
-
|
-0.2393
|
-1.196
|
-3.247
|
-5.342
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
02/02/21
|
02/02/21
|
27/10/21
|
24/10/22
|
27/10/23
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
0
|
1.87
|
5.45
|
0.51
|
1.05
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-0.24
|
-1.2
|
-3.25
|
-5.34
|
ROE (net income / shareholders' equity)
|
-
|
-72.2%
|
-77.8%
|
-288%
|
-1,148%
|
ROA (Net income/ Total Assets)
|
-
|
-43.8%
|
-47%
|
-144%
|
-191%
|
Assets
1 |
-
|
1.536
|
6.088
|
5.112
|
3.542
|
Book Value Per Share
|
-
|
0.1000
|
0.1600
|
-0.0100
|
0.0400
|
Cash Flow per Share
|
-
|
0.1000
|
0.1500
|
0.0100
|
0.0600
|
Capex
|
-
|
-
|
-
|
-
|
0.07
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
02/02/21
|
02/02/21
|
27/10/21
|
24/10/22
|
27/10/23
|
|
1st Jan change
|
Capi.
|
---|
| -36.91% | 48.81M | | +25.69% | 47.86B | | +46.90% | 41.42B | | -3.46% | 40.66B | | -6.20% | 28.92B | | +9.17% | 25.55B | | -20.42% | 19.27B | | +28.07% | 12.14B | | +0.17% | 12.15B | | -1.24% | 11.99B |
Other Biotechnology & Medical Research
|